**Question:** The Antiepileptic drug, Phenytoin therapeutic blood level is

A. 10-20 µg/mL
B. 12-20 µg/mL
C. 10-25 µg/mL
D. 10-30 µg/mL

**Correct Answer:** B. 12-20 µg/mL

**Core Concept:** Phenytoin is a widely used antiepileptic drug that works by inhibiting the action of voltage-gated sodium channels in the central nervous system, thereby reducing neuronal excitability and preventing seizures. The therapeutic range for phenytoin levels is crucial for optimal drug efficacy and minimizing side effects.

**Why the Correct Answer is Right:** The correct therapeutic range for phenytoin is 12-20 µg/mL (120-200 nmol/L). This range ensures that the drug is effective in controlling seizures while minimizing the risk of adverse effects such as neuropathy, gum hyperplasia, and impaired intellectual development in children.

**Why Each Wrong Option is Incorrect:**

A. 10-20 µg/mL (100-200 nmol/L) is too narrow a range and may result in suboptimal drug efficacy or excessive side effects.

C. 10-25 µg/mL (100-250 nmol/L) is too broad and could lead to underdosing and potential seizure recurrence or overtreatment with potential side effects.

D. 10-30 µg/mL (100-300 nmol/L) is too wide and may lead to suboptimal drug effectiveness or excessive side effects.

**Clinical Pearl:** Monitoring Phenytoin levels in patients receiving the drug is essential to ensure therapeutic efficacy, minimize side effects, and prevent drug-induced neurotoxicity. A thorough understanding of the drug's pharmacokinetics, pharmacodynamics, and clinical indications is crucial for optimal management of epileptic patients.

**Why the Correct Answer is Right:** The therapeutic range for phenytoin is chosen based on its pharmacokinetic properties, which include a short half-life (approximately 10-12 hours) and linear pharmacokinetics (dose-proportional increase in plasma concentrations). Maintaining a therapeutic range within the 12-20 µg/mL (120-200 nmol/L) ensures both seizure control and reduced risk of adverse effects, which is crucial for managing patients with epilepsy and other neurological disorders.